Immutep Ltd

Immutep Insider Deals Signal Strategic Upswing and Potential Orphan‑Drug Breakout

Immutep insider buying sparks bullish buzz as performance‑right vesting aligns with 2026‑28 milestones, hinting at a possible orphan‑drug breakthrough.

Immutep Ltd
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

16/04/2026, 12:23

5 minutes to read

Immutep Insider Holdings Show Mixed Signals Amid IMP761 Trial & Performance-Right Grants

Insider activity shows Immutep’s CEO holds 4 m shares while awaiting key milestones like IMP761 trial results and a Q3 2026 root‑cause report—patience amid upside potential.

Immutep Ltd
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

08/04/2026, 18:42

4 minutes to read